Armis BioPharma
Manufacturing · Colorado, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2401 Research Blvd Ste 205, Fort Collins...Website
www.armisbiopharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Armis BioPharma
Armis Biopharma specializes in next-generation antimicrobial solutions focused on wound healing, disinfecting, and decontamination. Their patented Veriox® technology platform addresses antimicrobial resistance by providing targeted therapies that eliminate a wide range of pathogens, including bacteria and viruses. The company aims to reduce the incidence and impact of infections that cause human suffering and death, making their products beneficial for hospitals, insurers, and patients. Armis Biopharma is dedicated to developing innovative antimicrobial therapies to combat preventable infections and improve healthcare outcomes.Explore more
Armis BioPharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Armis BioPharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Armis BioPharma has new funding data
Click to see if Armis BioPharma had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Armis BioPharma launches new products
Congratulate Masked Content for being promoted to Masked Content at Armis BioPharma
Check out if Armis BioPharma is spiking on competitors!
Check if Armis BioPharma has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Armis BioPharma, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Armis BioPharma recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Armis BioPharma as Masked Content
Find 3 more new buyers
Compare Similar Companies to Armis BioPharma
Compare insights from companies similar to Armis BioPharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Armis BioPharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Armis BioPharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Armis BioPharma.
Armis BioPharma financials insights
Gather financial insights about Armis BioPharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$117K
2025
Private Equity
$1M
Armis BioPharma Tech Stack
A closer look at the technologies used by Armis BioPharma
Armis BioPharma News & Media
Armis Biopharma Announces 510(k) Clearance for VeriCyn® Wound Wash
FORT COLLINS, Colo., May 31, 2023 /PRNewswire/ -- Armis Biopharma, Inc. announced today the U.S. Food and Drug Administration (FDA) has provided 510(k) clearance for the VeriCyn® Wound Wash medical device. VeriCyn® Wound Wash provides skin-friendly wound care with a unique formula that is...Armis Biopharma Announces FDA Approval of VeriFixx™ Small Bone Implant
FORT COLLINS, Colo., Nov. 19, 2020 /PRNewswire/ -- Armis Biopharma, Inc. announced today the U.S. Food and Drug Administration (FDA) has approved the VeriFixx™ Small Bone Implant for the fixation of osteotomies and reconstruction of the lesser toes following correction procedures for...Armis Biopharma Announces Grant Award from the National Institutes of Health
FORT COLLINS, Colo., Nov. 9, 2020 /PRNewswire/ -- Armis Biopharma, Inc. announced that the National Institutes of Health (NIH) recently awarded the company a grant in the amount of $423,048 to support development of a novel product for skin decontamination after exposure to chemical...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Armis BioPharma
Sign Up For FreeTo access detailed company insights
Armis Biopharma specializes in next-generation antimicrobial solutions focused on wound healing, disinfecting, and decontamination. Their patented Veriox® technology platform addresses antimicrobial resistance by providing targeted therapies that eliminate a wide range of pathogens, including bacteria and viruses. The company aims to reduce the inc... Read More
